Please assess the completion status of the following clinical trial:

Trial Title: Berberine Hyperglycemic Clamp

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Adult healthy male, aged ≥18 and ≤45 years old.~2. Subject/ legal representative is able to understand and sign informed consent form.~3. Body mass index (BMI) 18-25 kg/m2.~4. Normal oral glucose tolerance test prior to study.~5. No family history of diabetes mellitus.~6. No medication treatment within 4 weeks prior to baseline visit and during the study.~7. Willing and able to comply with all study-related procedures, including not incorporating significant changes in diet.~Exclusion Criteria:~1. Infection with hepatitis (A, B, or C), HIV and syphilis.~2. History of allergic reaction to berberine or any component in the formulation of the study drugs.~3. Cumulative amount of blood loss (eg. blood donation) over 400mL within 3 months prior to baseline visit and during the study.~4. Alcohol drinking within 2 weeks prior to baseline visit and during the study.~5. Use of illegal drugs or positive in urine drugs screen.~6. Smoke during the study.

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Berberine treatment (Type: EXPERIMENTAL): None
- Placebo control (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).